The Pharma Letter23h
NICE recommends Breyanzi for B-cell lymphomas
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...
CAR-TCR Summit Coverage – Track Latest Insights on Novel CAR-T Cell Therapies for B-Cell Malignancies | DelveInsight
A case study on how DelveInsight supported a client with a focused CAR-TCR Summit coverage plan to gain exclusive insights into CAR-T therapies for B-cell malignancies.New York, USA, Feb. 21, 2025 (GL ...
Hosted on MSN16h
NICE green lights two blood cancer therapies for NHS use
BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
The Irish connection to Banksy’s Crude Oil (Vettriano), now expected to fetch as much as €6m at auction
Image of the week this week comes courtesy of Banksy, whose painting Crude Oil (Vettriano) is set to go to auction at Sotheby’s in London early next month, having been put on the block by the man who ...
Researchers investigate rare side effect of blood cancer immunotherapy
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...